Search for Clinical Trial Results

Sponsored By

Angioedemas, Hereditary - 13 Studies Found

Status Study
Recruiting Study Name: Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Date: 2013-04-04
Interventions: Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc
Completed Study Name: A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Date: 2012-02-16
Completed Study Name: Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema (HAE)
Date: 2005-12-05
Interventions:
  • Drug: ecallantide dose of 30 m
Recruiting Study Name: Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Date: 2016-08-10
Interventions:
  • Drug: BCX7353 Plasma kallikrei
Completed Study Name: Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Date: 2014-01-30
Interventions:
  • Biological: CINRYZE 500 500 Un
Active, not recruiting Study Name: Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema (HAE)
Date: 2016-08-09
Interventions:
  • Drug: CINRYZE 500 U IV infusio
Active, not recruiting Study Name: Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Date: 2015-10-20
Interventions: Drug: C1 esterase inhibitor [human] liquid C1 Esterase Inhibitor [Human] Liquid administered Subcutaneou
Terminated Study Name: Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema
Condition:
  • Hereditary Angioedema
  • HAE

Date: 2016-01-20
Interventions: Drug: avoralstat Other Name: BCX4161
Active, not recruiting Study Name: A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Date: 2014-12-10
Interventions: Biological: C1-esterase inhibitor
Recruiting Study Name: Biomarker for Hereditary Angioedema Disease Type 1
Condition:
  • Hereditary AngioEdema
  • Angioedema, Heredit
    Date: 2017-01-18
Next >>>